Unit 2: Biosafety regulatory framework - Subjective Questions

India regulates GMOs under the Environment (Protection) Act, 1986 through the Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms/Genetically Engineered Organisms or Cells, 1989 (commonly called the Rules 1989). These rules are jointly implemented by the Ministry of Environment, Forest and Climate Change (MoEF&CC) and the Department of Biotechnology (DBT).

The framework operates through six competent authorities arranged in a hierarchy:

• RDAC (Recombinant DNA Advisory Committee): Advisory body that reviews developments in biotechnology at national and international level.
• IBC (Institutional Biosafety Committee): Set up at each institution handling GMOs; the base-level monitoring unit.
• RCGM (Review Committee on Genetic Manipulation): Monitors ongoing research and small-scale field trials.
• GEAC (Genetic Engineering Appraisal/Approval Committee): Apex approval body for large-scale use and environmental release.
• SBCC (State Biotechnology/Biosafety Coordination Committee): Monitoring at the state level.
• DLC (District Level Committee): Monitoring at the district level.

This multi-tiered structure ensures advisory, review, approval, and monitoring functions are separated across national, state, and district levels for safe handling of GMOs.

The Recombinant DNA Advisory Committee (RDAC) is an advisory committee constituted by the Department of Biotechnology (DBT). It functions at the national level to guide the safe use of recombinant DNA technology.

Composition:

• Experts drawn from various biotechnology and allied scientific disciplines.
• Representatives from research institutions and regulatory bodies.

Functions:

• Takes note of national and international developments in biotechnology.
• Recommends suitable safety regulations for India in recombinant research, use, and applications.
• Prepares and periodically revises biosafety guidelines (e.g., the Recombinant DNA Guidelines, 1990).
• Acts purely in an advisory capacity; it does not grant approvals.

RDAC essentially provides the scientific and policy backbone on which the operational committees (IBC, RCGM, GEAC) function.

The Institutional Biosafety Committee (IBC) is the first and base-level regulatory unit established in every institution engaged in recombinant DNA research or handling of GMOs.

Composition:

• Head of the institution or nominee as chairperson.
• Three or more scientists engaged in DNA work or molecular biology.
• A medical expert/biosafety officer.
• A nominee of the DBT (RCGM nominee).

Responsibilities:

• Registers and reviews all rDNA projects within the institution.
• Ensures adherence to biosafety guidelines and provides appropriate containment facilities.
• Prepares an on-site emergency plan in case of accidental release.
• Maintains records and submits periodic reports to RCGM.
• Acts as the interface between the researcher and higher regulatory authorities.

The IBC therefore ensures that safety is built into research at the very site where the work is carried out.

The Genetic Engineering Approval Committee (GEAC) — now called the Genetic Engineering Appraisal Committee — is the apex body under the Ministry of Environment, Forest and Climate Change (MoEF&CC) for approvals relating to GMOs.

Functions and Powers:

• Grants approval for large-scale use of GMOs and products in research and industrial production.
• Approves the environmental release and commercialization of GMOs (e.g., Bt cotton).
• Approves import, export, transport, manufacture, and use of hazardous microorganisms and genetically engineered products.
• Has the authority to take punitive action under the Environment (Protection) Act, 1986.
• Supervises implementation of the Rules 1989.

Significance: GEAC is the final decision-making authority for the environmental release of GMOs, making it the most powerful body in India's biosafety framework.

Both the SBCC and DLC are monitoring bodies in India's biosafety framework, but they operate at different administrative levels.

State Biosafety Coordination Committee (SBCC):

• Functions at the state level.
• Headed by the Chief Secretary or Secretary of the concerned state department.
• Monitors and coordinates the safety of GMO-related activities across the state.
• Has powers to inspect, investigate, and take punitive action for violations.
• Acts as a nodal agency at the state level for biosafety.

District Level Committee (DLC):

• Functions at the district level.
• Headed by the District Collector/Magistrate.
• Monitors safety regulations in installations engaged in GMO use within the district.
• Investigates compliance and violations locally.
• Reports to the SBCC and GEAC.

Key difference: SBCC handles state-wide coordination and policy monitoring, while DLC provides ground-level, local enforcement and surveillance.

The Recombinant DNA Guidelines (1990) were issued by the Department of Biotechnology (DBT) to regulate rDNA research and applications in India.

Salient Features:

• Provided guidelines for research activities involving GMOs, hazardous microorganisms, and gene manipulation.
• Classified experiments into categories based on risk levels and prescribed containment requirements.
• Defined physical and biological containment measures for laboratories.
• Laid down safety norms for large-scale operations and industrial production.
• Provided a framework for import and shipment of genetically engineered materials.
• Emphasized the establishment of the committee structure (IBC, RCGM, GEAC) for oversight.

These guidelines formed the foundational document for regulating biotechnology in India and were later supplemented by revised guidelines for specific areas.

The Revised Guidelines for Research in Transgenic Plants (1998) were issued by the Department of Biotechnology to specifically address the growing field of plant genetic engineering in India.

Key Provisions:

• Detailed procedures for contained research, greenhouse studies, and field trials of transgenic plants.
• Classified experiments and field trials into stages: limited field trials, multi-location trials, and large-scale release.
• Prescribed norms for import and export of transgenic planting material.
• Defined the roles of IBC, RCGM, and GEAC in approving transgenic plant work at successive stages.
• Provided guidelines on containment facilities for transgenic plant research.
• Addressed the assessment of environmental and food safety before commercial release.

These guidelines gave a step-wise regulatory roadmap for moving a transgenic plant from the laboratory to the field and eventually to commercialization.

Farmers' Rights refer to the rights of farmers to save, use, sow, resow, exchange, share, or sell their farm produce, including seed of protected varieties, in the same manner they were entitled before the enactment of intellectual property laws over plant varieties.

In India, these rights are protected under the Protection of Plant Varieties and Farmers' Rights (PPV&FR) Act, 2001.

Key aspects of Farmers' Rights:

• Right to save and reuse seed from their own harvest.
• Right to register traditional/farmer varieties they have developed or conserved.
• Right to reward and recognition for conserving genetic resources (Gene Fund benefit sharing).
• Protection from innocent infringement — farmers not penalized if unaware of variety rights.
• Right to compensation if a registered variety fails to perform as promised.

Significance:

• Recognizes the contribution of farmers as conservers and breeders of biodiversity.
• Balances breeders' commercial interests with farmers' livelihood security.
• Preserves traditional agricultural practices and food security.

Plant Breeders' Rights (PBR) are intellectual property rights granted to the breeder of a new plant variety, giving exclusive control over the propagating material of that variety for a specified period.

Scope (under the PPV&FR Act, 2001):

• Exclusive right to produce, sell, market, distribute, import, or export the protected variety.
• Applies to varieties that are Novel, Distinct, Uniform, and Stable (NDUS criteria).
• Protection period: generally 15 years for crops and 18 years for trees and vines.

Importance:

• Incentivizes innovation by allowing breeders to recover investment in research.
• Encourages the development of improved, high-yielding varieties.
• Attracts private investment into the seed and agriculture sector.
• Provides legal recognition and protection against unauthorized use.

PBR balances the innovator's commercial interest with the broader goal of agricultural development, while the Indian Act uniquely couples it with Farmers' Rights.

Both rights are recognized under the PPV&FR Act, 2001 but protect different stakeholders.

Summary: Farmers' Rights are welfare and conservation oriented, whereas Plant Breeders' Rights are commercial and innovation oriented. India's law is notable for granting both in a balanced manner.

GMOs in India are regulated primarily under environmental legislation.

Key Legislative Basis:

• Environment (Protection) Act, 1986: The parent legislation empowering the central government to protect and improve the environment.
• Rules 1989 (Rules for Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms/Genetically Engineered Organisms or Cells): The specific rules notified under the 1986 Act that establish the regulatory committees and procedures.
• Supported by DBT Guidelines (rDNA Guidelines 1990, Revised Guidelines for Research in Transgenic Plants 1998).
• Related statutes: Biological Diversity Act, 2002, Food Safety and Standards Act, 2006, and the PPV&FR Act, 2001 for related aspects.

Scope of Rules 1989:

• Covers research, manufacture, import, storage, and release of GMOs.
• Establishes six competent authorities (RDAC, IBC, RCGM, GEAC, SBCC, DLC).

Thus the framework rests on statutory rules backed by the Environment Protection Act, with technical guidelines providing operational detail.

The Review Committee on Genetic Manipulation (RCGM) functions under the Department of Biotechnology (DBT) and serves as the monitoring committee for ongoing rDNA research.

Functions:

• Monitors safety-related aspects of ongoing research projects and activities involving GMOs.
• Reviews all approved rDNA projects at the institutional level.
• Brings out manuals and guidance procedures for regulating GMO research, use, and handling.
• Grants permission for the conduct of small-scale/limited field trials of transgenic plants.
• Recommends projects to GEAC for further large-scale approval.
• May visit and inspect facilities to verify compliance.

Position in hierarchy: RCGM sits between the IBC (institution level) and GEAC (apex approval level), acting as the crucial review and monitoring link for research-stage activities.

Containment refers to the practices and facilities that prevent the escape of GMOs and hazardous organisms into the environment during research.

Physical Containment (PC):

• Use of engineering controls and equipment such as biosafety cabinets, sealed rooms, and filtered air systems.
• Classified into levels (e.g., BSL-1 to BSL-4) based on the risk of the organism.
• Includes laboratory design, access control, and waste disposal measures.

Biological Containment (BC):

• Use of weakened or disabled host organisms and vectors that cannot survive outside the laboratory.
• Ensures that even if released, the organism cannot establish or spread in the natural environment.
• Example: using laboratory strains of E. coli that lack survival capacity in the wild.

Purpose: Combining physical and biological containment provides layered safety, matching the containment level to the assessed risk category of the experiment.

The approval of a transgenic plant follows a stepwise pathway involving multiple committees:

1. Laboratory/contained research: Registered and monitored by the IBC at the institution level following the 1990 and 1998 guidelines.

2. Greenhouse and limited field trials: The RCGM reviews containment and grants permission for small-scale/limited field trials.

3. Multi-location field trials (large-scale trials): Requires approval of the GEAC, which evaluates biosafety data including environmental and food safety.

4. Environmental release/commercialization: Final approval granted only by the GEAC under MoEF&CC.

5. Monitoring: Post-approval monitoring carried out by SBCC and DLC at state and district levels.

Key point: At each stage, biosafety data (toxicity, allergenicity, gene flow, environmental impact) must be generated and evaluated before progression to the next stage.

The Protection of Plant Varieties and Farmers' Rights (PPV&FR) Act, 2001 is Indian legislation enacted to provide an effective system for the protection of plant varieties, the rights of farmers, and plant breeders.

Major Objectives:

• To establish an effective system for protection of plant varieties.
• To recognize and protect the rights of farmers for their contribution in conserving and improving plant genetic resources.
• To protect plant breeders' rights to stimulate investment in research and development.
• To facilitate the growth of the seed industry and ensure availability of quality seeds.
• To comply with India's obligations under the TRIPS Agreement while safeguarding national interests.

Notable feature: India adopted a sui generis (unique) system that uniquely balances breeders' commercial rights with farmers' traditional rights, unlike the pure UPOV model.

For a plant variety to be registered and protected under the PPV&FR Act, 2001, it must satisfy the NDUS criteria:

• N – Novelty: The variety must not have been sold or disposed of for commercial exploitation earlier than a prescribed period before the filing date.
• D – Distinctiveness: The variety must be clearly distinguishable by at least one essential characteristic from any other known variety.
• U – Uniformity: The plants of the variety must be sufficiently uniform in their essential characteristics.
• S – Stability: The essential characteristics must remain unchanged after repeated propagation.

Additional requirement: The variety must be given a denomination (name) conforming to prescribed norms.

These criteria ensure that only genuinely new, identifiable, consistent, and reproducible varieties receive legal protection.

Composition of GEAC:

• Chairman: Special/Additional Secretary of the MoEF&CC.
• Co-chairman: A representative of the Department of Biotechnology.
• Members: Experts and representatives from various ministries and scientific institutions (ICAR, ICMR, CSIR, DBT, etc.).
• A Member Secretary from MoEF&CC.

Functions:

• Appraises and approves activities involving large-scale use of GMOs.
• Approves the environmental release and commercialization of GMOs.
• Grants permission for import, export, and manufacture of genetically engineered products.
• Empowered to take punitive action under the Environment (Protection) Act, 1986.

Landmark case: The approval of Bt cotton (Bollgard) in 2002 was a landmark decision by GEAC, making it the first commercially cultivated GM crop in India. GEAC's cautious handling of Bt brinjal (moratorium imposed in 2010) is another important instance highlighting its regulatory significance.

Although both operate under the DBT, RDAC and RCGM differ in nature and role.

Summary: RDAC frames the rules and advice, while RCGM implements monitoring and reviews the actual research activities.

A robust biosafety regulatory framework is essential to balance the benefits of biotechnology with the protection of human health and the environment.

Importance:

• Human health protection: Ensures GM foods and products are tested for toxicity and allergenicity before release.
• Environmental safety: Prevents adverse effects such as gene flow, loss of biodiversity, and harm to non-target organisms.
• Public confidence: Transparent regulation builds public trust in biotechnology products.
• Scientific advancement: A clear framework encourages responsible research and innovation.
• International trade & compliance: Helps India meet obligations under the Cartagena Protocol on Biosafety and TRIPS.
• Ethical governance: Ensures decisions consider socio-economic and ethical dimensions, not just technical ones.

For a biodiversity-rich, agriculture-dependent nation like India, such a framework safeguards farmers, consumers, and ecosystems while enabling the growth of the biotech sector.

The National Gene Fund is a financial mechanism created under the PPV&FR Act, 2001 to support the implementation of Farmers' Rights and reward conservation.

Sources of the Gene Fund:

• Benefit-sharing amounts received from breeders of protected varieties.
• Annual fees and royalties payable by breeders.
• Compensation and contributions from national/international organizations.

Uses of the Gene Fund:

• Rewards and recognition to farmers and communities who conserve and improve genetic resources.
• Support for ex-situ conservation by NGOs and institutions.
• Meeting expenses of benefit-sharing to the contributors of parental material used in a new variety.

Benefit-sharing concept:

• When a breeder uses genetic material conserved by a community/farmer to develop a new variety, a share of the commercial benefit must flow back to those contributors through the Gene Fund.

This mechanism operationalizes the principle of equitable sharing of benefits, recognizing farmers as key stewards of biodiversity.